Joanna Timmins

James Timmins currently works in a business role as a consultant and entrepreneur, and for spinoff companies from the Nevada Institute for Personalized Medicine, University of Nevada, Las Vegas. James has focused on research in Molecular Virology, Analytical Chemistry, Medicinal Chemistry and Biochemistry. His most recent publication is 'Gene Gun-Mediated IL-12 Gene Therapy Induces Antitumor Effects in the Absence of Toxicity: A Direct Comparison With Systemic IL-12 Protein Therapy'. However the bulk of his scientific career was as one of the first industrial biotech scientists specializing in viral vaccine product development.